Leucemia linfoblástica aguda infantil: una aproximación genómica

Secretaría de Salud. Subsecretaría de Prevención y Promoción de la Salud. Dirección General de Epidemiología 2011. Perfil Epidemiológico de Cáncer en Niños y Adolescentes. Ciudad de México; 2011. pp.155. Rivera-Luna, 2013, Incidence of childhood cancer among Mexican children registered under a public medical insurance program, Int J Cancer., 132, 1646, 10.1002/ijc.27771 Pérez-Saldívar, 2011, Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology, BMC Cancer., 11, 355, 10.1186/1471-2407-11-355 Pui, 2013, A 50-year journey to cure childhood acute lymphoblastic leukemia, Semin Hematol., 50, 185, 10.1053/j.seminhematol.2013.06.007 Hunger, 2012, Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group, J Clin Oncol., 30, 1663, 10.1200/JCO.2011.37.8018 Schultz, 2014, Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031, Leukemia., 28, 1467, 10.1038/leu.2014.30 Bhojwani, 2015, Biology of childhood acute lymphoblastic leukemia, Pediatr Clin North Am., 62, 47, 10.1016/j.pcl.2014.09.004 Lander, 2001, Initial sequencing and analysis of the human genome, Nature., 409, 860, 10.1038/35057062 Venter, 2001, The sequence of the human genome, Science., 291, 1304, 10.1126/science.1058040 Onciu, 2009, Acute lymphoblastic leukemia, Hematol Oncol Clin North Am., 23, 655, 10.1016/j.hoc.2009.04.009 http://www.cancer.gov/types/leukemia/hp/child-all-treatment-pdq#section/_1 Último acceso: Junio 2016. 2008 http://www.cancer.gov/types/leukemia/hp/child-all-treatment-pdq#section/_22. Último acceso: Junio 2016. Biondi, 2000, Biological and therapeutic aspects of infant leukemia, Blood., 96, 24, 10.1182/blood.V96.1.24 Mullighan, 2014, The genomic landscape of acute lymphoblastic leukemia in children and young adults, Hematology Am Soc Hematol Educ Program., 2014, 174, 10.1182/asheducation-2014.1.174 Pérez-Vera, 2005, Detection of ETV6 and RUNX1 gene rearrangements using fluorescence in situ hybridization in Mexican patients with acute lymphoblastic leukemia: experience at a single institution, Cancer Genet Cytogenet., 162, 140, 10.1016/j.cancergencyto.2005.03.018 Jiménez-Morales, 2008, BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients, Leuk Res., 32, 1518, 10.1016/j.leukres.2008.03.021 Bekker-Méndez, 2014, Prevalence of gene rearrangements in Mexican children with acute lymphoblastic leukemia: a population study-report from the Mexican Interinstitutional Group for the identification of the causes of childhood leukemia, Biomed Res Int., 2014, 210560, 10.1155/2014/210560 Verduzco-Rodríguez, 2012, Leucemia linfoblástica aguda hiperdiploide en niños, Rev Hematol Mex., 13, 172 Daniel-Cravioto, 2009, Genetic rearrangement MLL/AF4 is most frequent in children with acute lymphoblastic leukemias in Mexico City, Leuk Lymphoma., 50, 1352, 10.1080/10428190903015636 Rizzo, 2012, Key principles and clinical applications of “next-generation” DNA sequencing, Cancer Prev Res (Phila)., 5, 887, 10.1158/1940-6207.CAPR-11-0432 Ma, 2015, Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia, Nat Commun., 6, 6604, 10.1038/ncomms7604 Grabherr, 2011, Full-length transcriptome assembly from RNA-Seq data without a reference genome, Nat Biotecnol., 29, 644, 10.1038/nbt.1883 Bumgarner R. Overview of DNA microarrays: types, applications, and their future. Curr Protoc Mol Biol. 2013;Chapter 22:Unit 22.1. Pei, 2014, Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma, Cancer Genet., 207, 98, 10.1016/j.cancergen.2014.02.005 Yeoh, 2002, Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling, Cancer Cell., 1, 133, 10.1016/S1535-6108(02)00032-6 Watson, 2005, TaqMan applications in genetic and molecular toxicology, Int J Toxicol., 24, 139, 10.1080/10915810590948299 Korf, 2013, Integration of genomics into medical practice, Discov Med., 16, 241 Perez-Andreu, 2013, Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse, Nat Genet., 45, 1494, 10.1038/ng.2803 Walsh, 2014, Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia, Am J Hematol., 89, 721, 10.1002/ajh.23727 Perez-Andreu, 2015, A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults, Blood., 125, 680, 10.1182/blood-2014-09-595744 Mullighan, 2008, BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros, Nature, 453, 110, 10.1038/nature06866 Garza-Veloz, 2015, Identification of differentially expressed genes associated with prognosis of B acute lymphoblastic leukemia, Dis Markers., 2015, 828145, 10.1155/2015/828145 Suzuki, 2015, Influence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemia, Pediatr Int., 57, 572, 10.1111/ped.12682 Martinelli, 2009, IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report, J Clin Oncol., 27, 5202, 10.1200/JCO.2008.21.6408 Mullighan, 2009, JAK mutations in high-risk childhood acute lymphoblastic leukemia, Proc Natl Acad Sci U S A., 106, 9414, 10.1073/pnas.0811761106 Harvey, 2010, Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia, Blood., 115, 5312, 10.1182/blood-2009-09-245944 Harvey, 2010, Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome, Blood., 116, 4874, 10.1182/blood-2009-08-239681 Kuiper, 2010, IKZF1 deletions predict relapse in uniformly treated pediatric precur-sor B-ALL, Leukemia., 24, 1258, 10.1038/leu.2010.87 Virely, 2010, Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia, Leukemia., 24, 1200, 10.1038/leu.2010.63 Coustan-Smith, 2009, Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia, Lancet Oncol., 10, 147, 10.1016/S1470-2045(08)70314-0 Holmfeldt, 2013, The genomic landscape of hypodiploid acute lymphoblastic leukemia, Nat Genet., 45, 242, 10.1038/ng.2532 Shah, 2013, A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia, Nat Genet., 45, 1226, 10.1038/ng.2754 Stieglitz, 2013, Genetic predispositions to childhood leukemia, Ther Adv Hematol., 4, 270, 10.1177/2040620713498161 Powell, 2013, Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing, Pediatr Blood Cancer., 60, E1, 10.1002/pbc.24417 Topka, 2015, Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia, PLoS Genet., 11, e1005262, 10.1371/journal.pgen.1005262 Infante-Rivard, 2002, Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and polymorphisms of carcinogen-metabolizing genes, Epidemiology., 13, 277, 10.1097/00001648-200205000-00007 Brisson, 2015, Genetic susceptibility in childhood acute leukaemias: a systematic review, Ecancermedicalscience., 9, 539, 10.3332/ecancer.2015.539 Yang, 2010, ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence, Leukemia., 24, 894, 10.1038/leu.2009.277 Xu, 2012, ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia, J Clin Oncol., 30, 751, 10.1200/JCO.2011.38.0345 Xu, 2013, Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations, J Natl Cancer Inst., 105, 733, 10.1093/jnci/djt042 Wang, 2013, Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population, Gene., 524, 203, 10.1016/j.gene.2013.04.028 Zeng, 2014, Associations between AT-rich interactive domain 5B gene polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis, Asian Pac J Cancer Prev., 15, 6211, 10.7314/APJCP.2014.15.15.6211 Hsu, 2015, Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children, Cancer Causes Control., 26, 609, 10.1007/s10552-015-0550-3 Rudant, 2015, ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study, PLoS One., 10, e0121348, 10.1371/journal.pone.0121348 Wang, 2015, CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls, Ann Hematol., 94, 181, 10.1007/s00277-014-2186-x Migliorini, 2013, Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype, Blood., 122, 3298, 10.1182/blood-2013-03-491316 Liao, 2016, Association Between PIP4K2A Polymorphisms and Acute Lymphoblastic Leukemia Susceptibility, Medicine (Baltimore)., 95, e3542, 10.1097/MD.0000000000003542 Infante-Rivard, 2002, GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water: effect on childhood leukemia, Environ Health Perspect., 110, 591, 10.1289/ehp.02110591 Clavel, 2005, Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy, Eur J Cancer Prev, 14, 531, 10.1097/00008469-200512000-00007 da Silva Silveira, 2009, Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia, Leuk Res., 33, 898, 10.1016/j.leukres.2008.12.006 Chang, 2010, Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia, Cancer Epidemiol Biomarkers Prev., 19, 2152, 10.1158/1055-9965.EPI-10-0389 Han, 2013, Novel insights into etiologies of leukemia: a HuGE review and meta-analysis of CYP1A1 polymorphisms and leukemia risk, Am J Epidemiol., 178, 493, 10.1093/aje/kwt016 Vijayakrishnan, 2010, Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis, Haematologica., 95, 1405, 10.3324/haematol.2010.022095 Zhang, 2013, Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies, PLoS One., 8, e80687, 10.1371/journal.pone.0080687 Bhatia, 2002, Racial and ethnic differences in survival of children with acute lymphoblastic leukemia, Blood., 100, 1957, 10.1182/blood-2002-02-0395 Linabery, 2008, Trends in childhood cancer incidence in the U.S. (1992-2004), Cancer., 112, 416, 10.1002/cncr.23169 Chow, 2010, Childhood cancer in relation to parental race and ethnicity: a 5-state pooled analysis, Cancer., 116, 3045, 10.1002/cncr.25099 Dores, 2012, Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007, Blood., 119, 34, 10.1182/blood-2011-04-347872 Aldrich, 2006, Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California, Cancer Epidemiol Biomarkers Prev., 15, 578, 10.1158/1055-9965.EPI-05-0833 Lim, 2014, Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia, Cancer., 120, 955, 10.1002/cncr.28531 Swinney, 2011, Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children, Cancer Epidemiol Biomarkers Prev., 20, 1537, 10.1158/1055-9965.EPI-10-1265 Piwkham, 2011, Multilocus association of genetic variants in MLL, CREBBP, EP300, and TOP2A with childhood acute lymphoblastic leukemia in Hispanics from Texas, Cancer Epidemiol Biomarkers Prev., 20, 1204, 10.1158/1055-9965.EPI-11-0059 Hungate, 2016, A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology, Nat Commun., 7, 10635, 10.1038/ncomms10635 Wang, 2015, The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies, Onco Targets Ther., 8, 3277 Meza-Espinoza, 2009, XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastiC leukemia, Genet Mol Res., 8, 1451, 10.4238/vol8-4gmr687 Kohlmann, 2004, Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients, Leukemia., 18, 63, 10.1038/sj.leu.2403167 Hogan, 2011, Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies, Blood., 118, 5218, 10.1182/blood-2011-04-345595 Mi, 2007, MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia, Proc Natl Acad Sci USA., 104, 19971, 10.1073/pnas.0709313104 Zhang, 2009, MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia, PLoS One., 4, e7826, 10.1371/journal.pone.0007826 Wang, 2010, MicroRNAs expression signatures are associated with lineage and survival in acute leukemias, Blood Cells Mol Dis., 44, 191, 10.1016/j.bcmd.2009.12.010 Figueroa, 2013, Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia, J Clin Invest., 123, 3099, 10.1172/JCI66203 Knoechel, 2014, An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia, Nat Genet., 46, 364, 10.1038/ng.2913 Mei, 2014, Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia, Cancer Sci., 105, 463, 10.1111/cas.12370 Nemes, 2015, Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia, Pathol Oncol Res., 21, 597, 10.1007/s12253-014-9861-z Musialik, 2015, Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia, Blood Res., 50, 26, 10.5045/br.2015.50.1.26 Duyu, 2014, Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia, Biomed Res Int., 2014, 967585, 10.1155/2014/967585 Lee, 2009, Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk, Leuk Res., 33, 250, 10.1016/j.leukres.2008.06.031 Chokkalingam, 2012, Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia, Cancer Causes Control., 23, 1367, 10.1007/s10552-012-9947-4 Urayama, 2007, MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia, Cancer Epidemiol Biomarkers Prev., 16, 1172, 10.1158/1055-9965.EPI-07-0007 Lupo, 2014, Gene-environment interactions and the risk of childhood acute lymphoblastic leukemia: exploring the role of maternal folate genes and folic Acid fortification, Pediatr Hematol Oncol., 31, 160, 10.3109/08880018.2013.825684 Martinelli, 2009, New targets for Ph+ leukaemia therapy, Best Pract Res Clin Haematol., 22, 445, 10.1016/j.beha.2009.08.002 2008 Burmeister, 2010, Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia, Haematologica., 95, 241, 10.3324/haematol.2009.011346 Mullighan, 2009, Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia, N Engl J Med., 360, 470, 10.1056/NEJMoa0808253 Coustan-Smith, 2011, New markers for minimal residual disease detection in acute lymphoblastic leukemia, Blood., 117, 6267, 10.1182/blood-2010-12-324004 Yang, 2008, Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia, Blood., 112, 4178, 10.1182/blood-2008-06-165027 Wang, 2008, Acute promyelocytic leukemia: from highly fatal to highly curable, Blood., 111, 2505, 10.1182/blood-2007-07-102798 Druker, 2009, Perspectives on the development of imatinib and the future of cancer research, Nat Med., 15, 1149, 10.1038/nm1009-1149 Pui, 2011, Biology, risk stratification, and therapy of pediatric acute leukemias: an update, J Clin Oncol., 29, 551, 10.1200/JCO.2010.30.7405 Yang, 2013, Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia, Methods Mol Biol., 999, 273, 10.1007/978-1-62703-357-2_20 Hoffman, 2014, PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics, Am J Med Genet C Semin Med Genet., 66C, 45, 10.1002/ajmg.c.31391 Lennard, 2015, Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics, Br J Haematol., 169, 228, 10.1111/bjh.13240 Cheok, 2009, Pharmacogenetics in acute lymphoblastic leukemia, Semin Hematol., 46, 39, 10.1053/j.seminhematol.2008.09.002 Evans, 2013, A healthcare system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigm, Clin Pharmacol Ther., 94, 224, 10.1038/clpt.2013.9 Bell, 2014, Development and use of active clinical decision support for preemptive pharmacogenomics, J Am Med Inform Assoc., 21, e93, 10.1136/amiajnl-2013-001993 Portell, 2014, Novel targeted therapies in acute lymphoblastic leukemia, Leuk Lymphoma., 55, 737, 10.3109/10428194.2013.823493 Kebriaei, 2015, Future of therapy in acute lymphoblastic leukemia (ALL)-potential role of immune-based therapies, Curr Hematol Malig Rep., 10, 76, 10.1007/s11899-015-0251-8 Moreno-Guerrero, 2013, Análisis de polimorfismos genéticos de la tiopurina S-metiltransferasa (TPMT) en pacientes pediátricos mexicanos con cáncer, Rev Invest Clin., 65, 156 Gutiérrez-Álvarez, 2016, Involvement of MTHFR and TPMT genes in susceptibility to childhood acute lymphoblastic leukemia (ALL) in Mexicans, Drug Metabol Personal Ther., 31, 41, 10.1515/dmpt-2015-0036